The global source for hematology education, practice and research

Disclaimer
Privacy statement

ISSN: 1478-1247

Home

Latest:

Breaking news.
8 March 2010	MDS drug refused in UK Britain's cost watchdog has courted fresh controversy by refusing permission for a novel drug for a rare hematological condition.
8 March 2010	Test for chronic graft-vs-host disease A new tool has been developed which may improve screening and assessment of chronic graft versus host disease (cGVHD).
8 March 2010	Quebec disorder solved Hematologists have found a genetic cause of a rare bleeding condition that affects people in Canada.

Summaries of key papers selected by the editors.

The best reviews from the journals.

Peer-reviewed articles summarizing hot topics, written specially for Bloodmed.com:

2nd London Lymphoma Forum
Robert Marcus and Chris McNamara, London Lymphoma Forum
Matriptase 2, a new and unexpected player in the iron field.
Dr Carole Beaumont, INSERM U773, Université Paris Diderot, site Bichat, 75018, Paris, France
Report from the XII congress of the International Society on Thrombosis and Haemostasis
Pamala Kanagasabapathy, Haemophilia Centre and Thrombosis Unit, Royal Free and University College Medical School

Current clinical guidelines.

Clinical Practice Guidelines for the management of atypical Haemolytic Uraemic Syndrome in the United Kingdom.
Taylor CM, Machin S, Wigmore SJ, and Goodship THJ on behalf of a working party from the Renal Association, the British Committee for Standards in Haematology and the British Transplantation Society.
British Journal of Haematology 2010; 148: 37-47.
Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care
Napolitano LM, Kurek S, Luchette FA, et al. for the American College of Critical Care Medicine of the Society of Critical Care Medicine and the Eastern Association for the Surgery of Trauma Practice Management Workgroup
Critical Care Medicine 2009; 37: 3124-3157
Venous thromboembolism: reducing the risk.
NICE
National Institute for Health and Clinical Excellence.Venous thromboembolism: reducing the risk. http://guidance.nice.org.uk/CG92